CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ (26,938)	$ 62,042	$ 76,149
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	58,246	28,452	27,249
Allowance for doubtful accounts	19	(7)	(16)
Amortization of deferred financing costs and original issue discount	1,746	964	964
Amortization of debt fair value adjustment	1,250	0	0
Loss on disposition of assets	148	38	218
Loss on extinguishment of debt	4,862	0	0
Change in assets and liabilities:
Accounts receivable	2,185	(44)	429
Inventories	31,426	(1,915)	(2,550)
Prepaid expenses and other current assets	2,410	2,133	3,111
Other long-term assets	(1,383)	(301)	149
Accounts payable	5,794	(1,609)	(4,967)
Deferred revenue	(20,395)	(10,484)	12,917
Accrued expenses and other current liabilities	(17,501)	(3,193)	3,553
Other long-term liabilities	314	(2)	(113)
Net cash provided by operating activities	44,969	78,421	118,878
Cash flows from investing activities:
Capital expenditures	(23,231)	(17,023)	(21,076)
Acquisition of CVR Nitrogen, LP, net of cash acquired	(63,869)	0	0
Proceeds from sale of assets	0	78	110
Net cash used in investing activities	(87,100)	(16,945)	(20,966)
Cash flows from financing activities:
Payment of financing costs	(10,688)	0	0
Proceeds on issuance of 2023 Notes, net of original issue discount	628,869	0	0
Proceeds on CRLLC Facility	300,000	0	0
Contribution from affiliate	507	0	0
Cash distributions to common unitholders – Affiliates	(27,633)	(48,650)	(54,877)
Cash distribution to common unitholders – Non-affiliates	(41,956)	(42,754)	(48,213)
Purchase of noncontrolling interest	(5,000)	0	0
Redemption of common units	0	(19)	(50)
Net cash provided by (used in) financing activities	47,759	(91,423)	(103,140)
Net increase (decrease) in cash and cash equivalents	5,628	(29,947)	(5,228)
Cash and cash equivalents, beginning of period	49,967	79,914	85,142
Cash and cash equivalents, end of period	55,595	49,967	79,914
Supplemental disclosures:
Cash paid for income taxes, net	14	35	55
Cash paid for interest, net of capitalized interest of $454, $9 and $85 in 2016, 2015 and 2014, respectively	53,110	5,916	5,819
Non-cash investing and financing activities:
Construction in progress additions included in accounts payable	3,871	1,030	1,066
Change in accounts payable related to construction in progress additions	(1,134)	(36)	(800)
Reduction of proceeds from 2023 Notes from original issue discount	16,131	0	0
Fair value of common units issued in a business combination	335,693	0	0
Fair value of debt assumed in a business combination	367,500	0	0
CRLLC
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based compensation	1,846	1,990	1,628
Third parties
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based compensation	940	357	157
6.50% notes, due 2021
Cash flows from financing activities:
Repayments of debt	(322,240)	0	0
CRLLC Facility
Cash flows from financing activities:
Repayments of debt	(300,000)	0	0
CRNF Credit Facility
Cash flows from financing activities:
Repayments of debt	(125,000)	0	0
Revolving credit facility
Cash flows from financing activities:
Repayments of debt	$ (49,100)	$ 0	$ 0